Surgery not always best for prostate

Findings of the PIVOT (Prostate Intervention Versus Observation Trial) study, which followed 731 men with prostate cancers over a 12-year period, were presented recently at the European Association of Urology congress in Paris.

The study, as yet unpublished and criticised by some clinicians for lacking detail, found that in almost half of the cases the tumour was slow-growing enough that patients, left untreated, could live for many years and die from something else.

This supported the stance of the Urological Society of Australia and New Zealand, a spokesman said.

Associate Professor Mark Frydenberg, chair of the society’s Urologic Oncology Special Advisory Group, said: “Men with low risk prostate cancer should be seriously considered for active surveillance, not surgery or other forms of treatment.

“While in some other countries, particularly the US, there has been concern about